FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive, HER2-Negative Breast Cancer
The United States Food and Drug Administration has authorized the use of Datroway (datopotamab deruxtecan-dlnk), developed by AstraZeneca (A...
Showing posts with label FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive. Show all posts
Showing posts with label FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive. Show all posts
Saturday, January 18, 2025
Posts
Posts